CLINICAL RESEARCH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Urticaria is a widespread dermatological disorder that substantially affects patients’ quality of life. Current data on its worldwide impact are crucial for healthcare planning and resource distribution. By analyzing the Global Burden of Disease (GBD) Study 2021, we evaluated the burden of urticaria across global, regional, and national levels.

Material and methods:
A comprehensive analysis was performed using data from the GBD 2021 study. Key metrics included prevalence, incidence, and age-standardized rates, all calculated per 100,000 people. The results were analyzed across demographic factors including age groups, gender, and geographical locations.

Results:
From 1990 to 2021, global urticaria metrics demonstrated relative stability, with female patients consistently reporting higher rates. During this period, the number of prevalent cases increased from approximately 48 million to 66.5 million, with the age-standardized prevalence rate (ASPR) showing a slight rise from 866 to 868 per 100,000 population. The number of incident cases increased from about 85 million to 117 million, while the age-standardized incidence rate (ASIR) showed a marginal increase from 1,529 to 1,534 per 100,000. The global age-standardized DALY rate reached 52.1 per 100,000 in 2021, ranging from 27.7 in Portugal to 88.4 in Nepal. The disease burden was most pronounced in low-middle SDI regions and lowest in high SDI areas. At the country level, Nepal recorded the highest burden across all metrics, while Portugal showed the lowest.

Conclusions:
Our analysis spanning three decades revealed that while the overall global burden of urticaria has remained relatively stable, there has been a modest upward trend in both prevalence and incidence. Notable disparities have emerged, with disproportionate impacts observed across different populations: females experience higher rates of the condition, and low-middle SDI regions shoulder a greater disease burden. These patterns highlight the importance of developing focused healthcare strategies and optimizing resource distribution, particularly in heavily affected regions. Given the inherent limitations of GBD data, these findings should be interpreted with appropriate caution.
REFERENCES (33)
1.
Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy 2018; 73: 1393-414.
 
2.
Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy 2011; 66: 317-30.
 
3.
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1204-22.
 
4.
Karimkhani C, Dellavalle RP, Coffeng LE, et al. Global skin disease morbidity and mortality: an update from the Global Burden of Disease Study 2013. JAMA Dermatol 2017; 153: 406-12.
 
5.
Pu Y, He L, Wang X, Zhang Y, Zhao S, Fan J. Global, regional, and national levels and trends in burden of urticaria: a systematic analysis for the Global Burden of Disease study 2019. J Glob Health 2024; 14: 4095.
 
6.
Liu X, Cao Y, Wang W. Burden of and trends in urticaria globally, regionally, and nationally from 1990 to 2019: Systematic analysis. JMIR Public Health Surveill 2023; 9: e50114.
 
7.
Murray CJL, Lopez AD. Measuring global health: motivation and evolution of the Global Burden of Disease Study. Lancet 2017; 390: 1460-4.
 
8.
Hay RJ, Johns NE, Williams HC, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Investig Dermatol 2014; 134: 1527-34.
 
9.
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2024; 403: 2133-61.
 
10.
Mathew G, Agha R, Albrecht J, et al. STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg 2021; 96: 106165.
 
11.
Knoll M, Furkel J, Debus J, Abdollahi A, Karch A, Stock C. An R package for an integrated evaluation of statistical approaches to cancer incidence projection. BMC Med Res Methodol 2020; 20: 257.
 
12.
Li S, Chen H, Man J, et al. Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years. Cancer Med 2021; 10: 1889-99.
 
13.
Liu N, Yang D, Wu Y, et al. Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea. BMC Cancer 2022; 22: 826.
 
14.
Wu B, Li Y, Shi B, et al. Temporal trends of breast cancer burden in the Western Pacific Region from 1990 to 2044: implications from the Global Burden of Disease Study 2019. J Adv Res 2023; 59: 189-99.
 
15.
Fricke J, Ávila G, Keller T, et al. Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis. Allergy 2020; 75: 423-32.
 
16.
Maurer M, Abuzakouk M, Bérard F, et al. The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU. Allergy 2017; 72: 2005-16.
 
17.
Caffarelli C, Paravati F, El Hachem M, et al. Management of chronic urticaria in children: a clinical guideline. Ital J Pediatr 2019; 45: 101.
 
18.
Prescott SL, Larcombe D, Logan AC, et al. The skin microbiome: impact of modern environments on skin ecology, barrier integrity, and systemic immune programming. World Allergy Organ J 2017; 10: 29.
 
19.
Morgenstern V, Zutavern A, Cyrys J, et al. Atopic diseases, allergic sensitization, and exposure to traffic-related air pollution in children. Am J Resp Crit Care 2008; 177: 1331-7.
 
20.
Caubet JC, Ford LS, Sickles L, et al. Clinical features and resolution of food protein-induced enterocolitis syndrome: 10-year experience. J Allergy Clin Immunol 2014; 134: 382-9.
 
21.
Minciullo PL, Cascio A, Barberi G, Gangemi S. Urticaria and bacterial infections. Allergy Asthma Proc 2014; 35: 295-302.
 
22.
Kasperska-Zajac A, Brzoza Z, Rogala B. Sex hormones and urticaria. J Dermatol Sci 2008; 52: 79-86.
 
23.
Kolkhir P, Borzova E, Grattan C, Asero R, Pogorelov D, Maurer M. Autoimmune comorbidity in chronic spontaneous urticaria: a systematic review. Autoimmun Rev 2017; 16: 1196-208.
 
24.
Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-60.
 
25.
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1250-84.
 
26.
Khreis H, Kelly C, Tate J, Parslow R, Lucas K, Nieuwenhuijsen M. Exposure to traffic-related air pollution and risk of development of childhood asthma: a systematic review and meta-analysis. Environ Int 2017; 100: 1-31.
 
27.
Bønnelykke K, Sparks R, Waage J, Milner JD. Genetics of allergy and allergic sensitization: common variants, rare mutations. Curr Opin Immunol 2015; 36: 115-26.
 
28.
Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A, González-Aveledo L, Maurer M. Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria. J Eur Acad Dermatol Venereol 2017; 31: 964-71.
 
29.
Alpay A, Solak Tekin N, Tekin IÖ, Altinyazar HC, Koca R, Cınar S. Autologous serum skin test versus autologous plasma skin test in patients with chronic spontaneous urticaria. Dermat Res Pract 2013; 2013: 267278.
 
30.
Behrendt H, Ring J. Climate change, environment and allergy. Chem Immunol Allergy 2012; 96: 7-14.
 
31.
Maurer M, Giménez-Arnau AM, Sussman G, et al. Ligelizumab for chronic spontaneous urticaria. N Engl J Med 2019; 381: 1321-32.
 
32.
Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy 2018; 73: 1393-414.
 
33.
Abuabara K, Margolis DJ, Langan SM. The long-term course of atopic dermatitis. Dermatol Clin 2017; 35: 291-7.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top